Last Update: February 20, 2026    
     

 

 
Research Featured
 

John Greenspan, BDS, PhD: 1938 – 2023

Dr. Greenspan's research career spanned more than five decades and included numerous groundbreaking discoveries in the field of oral medicine. He was particularly interested in the relationship between oral health and HIV/AIDS, and his work helped establish the field of oral HIV/AIDS research.

Throughout his career and until the very end of his life, Dr. Greenspan remained a devoted teacher and mentor, inspiring and guiding generations of dental and medical investigators. He supervised or mentored over 120 physicians and dental scientists. He was generous with his guidance and advice to those he mentored.

 

Courtesy of: University of California San Francisco | School of Dentistry

 

 

New NIH-funded project aims to turn rare HIV cures into broadly applicable immunotherapy

News Medical | August 28, 2025

Grant Terminations in the US Threaten HIV Research and Future Progress

JAMA | August 21, 2025

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot 

Aidsmap | March 12, 2025

 

 

News Updates

PD-1 blockade reprograms antiviral immunity and reduces the HIV reservoir

Nature | February 2026

Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being tested

STAT | February 11, 2026

New vaccine platform promotes rare protective B cells

MIT News | February 5, 2026

HIV/AIDS Research

NIH | January 14, 2026

HIV/AIDS clinical trials at UCSF

UCSF | January 14, 2025

HIV/AIDS clinical trials at UCSD

UCSD | January 13, 2026

HIV/AIDS clinical trials at UCLA

UCLA | January 13, 2026

AIDS Research and Human Retroviruses

Sage | January 13, 2026

NICHD HIV Research Information

NIH | January 8, 2026

Effects of Two Anti-HIV-1 Regimens on Creatinine and Blood Lipids in Elderly People Living With HIV-1

Wiley | January 6, 2026

IAVI announces first vaccinations in IAVI G004, a Phase 1 clinical trial of a promising HIV vaccine approach

iavi | January 6, 2026

Interleukin-2 is a potent latency reversal agent in people with treated HIV-1

Science | December 19, 2025

How HIV Capsid Research Sparked a New Era in Prevention 

American Society for Microbiology | December 18, 2025

Researchers Identify Why Some People With HIV Achieve Remission After Antibody Treatment

Mass General Brigham | December 1, 2025

New Trials Hint That ‘Functional Cure’ for HIV May Be Within Reach, Helping Some Patients Achieve Lasting Remission

Smithsonian | December 1, 2025

‘Is this my last pill ever?’ UCSF therapy offers patients a hint at a cure for HIV

UC SF | December 1, 2025

Long-Term HIV Control: Could this Combination Therapy Be the Key?

UC SF | December 1, 2025

Subgingival Bacterial Microbiota Profile of People Living With HIV-1 Under HAART: A Systematic Review 

Spec Care Dentist. 2025 Nov-Dec;45(6):e70121. doi: 10.1111/scd.70121.

Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency

Nature | November 24, 2025

New AI investment aims to accelerate the search for an effective HIV vaccine

News Medical | November 18, 2025

 

 

 
             
2019 Archives 2020 Archives 2021 Archives 2022 Archives 2023 Archives 2024 Archives 2025 Archives